Engebretson, MarkJohn Connett2023-10-192023-10-192011-09-12https://hdl.handle.net/11299/257646Runtime 1:30 minutesThis resource is provided for informational purposes only and may not reflect current scientific knowledge or medical recommendations.Welcome to Public Health Moment from the University of Minnesota. Good news for those who suffer from chronic obstructive pulmonary disease – or COPD: A clinical trial involving more than 1,100 people has found that a common antibiotic called azithromycin can reduce the occurrence and severity of COPD exacerbations or flareups. COPD refers to a group of chronic lung diseases that block airflow. These include bronchitis and emphysema. Joining us today is professor John Connett, a University of Minnesota biostatistican, who led the study. John, can you explain how the study was conducted and summarize the key findings? It looks like there were some side effects, with loss of hearing being one of them. Can you talk about that? And what advice do you have for people who suffer from this? Any thing else you’d like to mention about this study? Thanks John. For Public Health Moment, I’m Mark Engebretson.enAudio